Hormonal Shifts Plus Sleepless Nights? Oxytocin May Help
Oxytocin appeared to influence mood disturbances brought on by the sleep disruptions associated with the dramatic hormonal shifts in the postpartum period as well as menopausal states, shedding light on oxytocin's potentially protective role in those times of mental health vulnerability.
METHODOLOGY:
Thirty-eight premenopausal women took part in two 5-night inpatient sleep experiment protocols — one under a normal hormonal state, and the other while undergoing estradiol suppression, mimicking the hormonal shifts of the postpartum and menopausal periods.
After 2 nights of uninterrupted sleep, participants were subjected to sleep interruptions for the following 3 nights, with similar sleep duration in both conditions.
They were assessed for serum oxytocin each evening and for mood disturbances, using the Profile of Mood States, each morning, in both estradiol states.
TAKEAWAY:
In both estradiol states, sleep interruptions were significantly associated with increased oxytocin levels (mean, 28.7 pg/mL before sleep interruption vs 36.4 pg/mL after; P = .002) and mood disturbances (5.5 vs 12.3; P = .0001).
Meanwhile, higher oxytocin levels before sleep disruption were associated with reductions in mood disturbances the following day.
Increases in mood disturbances resulting from sleep disruptions were also associated with increased oxytocin levels the following day.
IN PRACTICE:
'Millions of women struggle with mood symptoms during reproductive transitions, yet treatments often focus narrowly on antidepressants or hormone therapy,' said first author Irene Gonsalvez, MD, associate psychiatrist at Brigham and Women's Hospital and instructor at Harvard Medical School, both in Boston, in a press statement.
'Understanding oxytocin's potential as a natural mood modulator could help us better support women's mental health during these times,' she added.
The study showed that 'oxytocin levels rise in response to stress-related sleep disruption, and that women with higher oxytocin levels before disrupted sleep experienced less mood disturbance the next day,' Gonsalvez explained.
'These results point toward oxytocin as a potential biological buffer during periods of hormonal and emotional vulnerability.'
SOURCE:
The study was presented at ENDO 2025: The Endocrine Society Annual Meeting.
LIMITATIONS:
The authors noted that mechanistic studies are needed to better understand the direction and causality of the effects of oxytocin levels, mood, and sleep disruptions.
DISCLOSURES:
The research was supported by the Brigham and Women's Hospital Connors Center WHISPR Award, the Dupont-Warren HMS Research Fellowship, and the National Institute on Aging.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
ARLINGTON, Va., July 29, 2025 /PRNewswire/ -- A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029. The twelfth edition of Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition highlights how decentralization of healthcare, rapid innovation, and consumer-driven demand are reshaping how and where diagnostic tests are performed—from traditional clinical settings to homes, workplaces, and remote environments. "POC testing is no longer a fringe segment—it is a central pillar of modern diagnostics," said Melissa Elder, Senior Analyst at Kalorama Information. "We see industry leaders like Abbott, Dexcom, Roche, Danaher, and Exact Sciences innovating aggressively, with POC solutions spanning blood gases, infectious disease, colon cancer, glucose monitoring, and more." The report identifies major growth opportunities in oncology, stroke, dementia, cardiac markers, and glucose management. With transportable and handheld devices becoming more widely available, the reach of point-of-care testing is extending to urgent care centers, disaster relief zones, and at-home monitoring. While the market is recovering from the COVID-19 testing surge of 2020–2022, momentum continues thanks to emerging technologies and the expanding need for fast, accurate, and accessible diagnostics. Trends Shaping the Future of POC Diagnostics: Wearables and mobile health tools Telehealth integration CRISPR and microfluidics innovation Multiplexed and AI-enabled testing Regulatory challenges and LDT policy changes The rise of non-invasive and consumer-friendly testing China's expanding role in the global POC landscape Key Takeaways from the Report: $36 Billion in Global Revenues (2024): Driven by demand in physician offices, clinics, and mobile care, with steady mid-single-digit CAGR expected through 2029. Top Growth Areas: Oncology, stroke, dementia, cardiac, and continuous glucose monitoring (CGM). Next-Gen Tech Impact: Innovations in CRISPR diagnostics, biosensors, and AI are transforming point-of-care capabilities. POC Molecular Diagnostics Rise: Originally accelerated by COVID-19, molecular POC testing is gaining relevance in emergency care and field screening worldwide. Consumer-Led Prevention: Wearables and Bluetooth-enabled tools support proactive health monitoring. Market Leaders and Competitive Landscape "Abbott leads the global market with over 25% share due to its expansive POC portfolio," said Elder. "Dexcom and Roche are advancing CGM and coagulation testing, while Exact Sciences is driving growth in colon cancer diagnostics. Danaher's Beckman Coulter continues to deliver in blood, cancer, and infectious disease testing." An Essential Industry Resource The report is a vital tool for product developers, investors, and healthcare strategists navigating market trends and emerging opportunities. It answers critical questions such as: Where is POC testing growing fastest? What technologies are reshaping diagnostic accessibility? How are regulations and reimbursement shaping adoption? What are the most promising new test types and applications? What's Inside: Global market forecasts through 2029 In-depth segmentation across 10+ test categories Venue analysis (hospital, clinic, retail, home) Competitive landscape profiles and regulatory updates Access the Report Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition is now available: To request the report or schedule a briefing:Sheri Davie – Kalorama Information Sales For media inquiries:Richa Singh – VP, Strategic & Insights About Kalorama InformationKalorama Information, part of Science and Medicine Group, is a leading publisher of independent market research in medical diagnostics, biotechnology, and life sciences. Our reports help global healthcare organizations, investors, and innovators make informed decisions with confidence. View original content to download multimedia: SOURCE Kalorama Information
Washington Post
12 hours ago
- Washington Post
The FDA should stop scaring women about this menopause treatment
For years, the Food and Drug Administration has been warning women about hormone therapies to treat menopause symptoms. The agency requires all estrogen-containing products to display a black box safety label — the most severe packaging requirement — claiming that they increase the risk of breast cancer, heart attacks and dementia.
Gizmodo
13 hours ago
- Gizmodo
This Ancient Roman Artifact Is Also a 453 Million-Year-Old Fossil
Despite how Ross' paleontology career is treated by his companions in Friends, there's something special about finding the remains of creatures that lived millions if not billions of years before us. In fact, humanity's interest in paleontology isn't a modern development. Ancient Romans were just as fascinated by fossils. According to the ancient Roman historian Suetonius, Emperor Augustus established the first known paleontological museum at his villa on the island of Capri, where he showcased the bones of ancient 'giants' and 'monsters.' While paleontologists have yet to uncover such fantastical remains, a study published Thursday in the journal Science describes something that, in my opinion, is even more special—an ancient Roman amulet crafted from the fossil of a critter that lived between 453 and 460 million years ago. The researchers claim that the artifact 'represents the first documented trilobite in the Roman world and the earliest known reference to this fossil group—and the intentional manipulation of a trilobite specimen—in all of classical antiquity,' they wrote in the study. Trilobites are a group of marine arthropods that existed between 521 and 251 million years ago. It's also the 'third trilobite in the global archaeological record to have been collected and used by people over a thousand years ago,' they added. The rare artifact came to light in a Roman settlement in northwestern Spain called A Cibdá of Armea that existed from the first to the third century CE. The researchers suggest that the fossil itself originated in shale outcrops over 267 miles (430 kilometers) away from the Roman settlement. The trilobite likely reached the settlement via trade or as the property of someone from central Lusitania (a Roman province in Spain) moving to the region. Either way, someone clearly altered the fossil. 'The Armea trilobite fragment unquestionably shows evidence of anthropic work, particularly on the underside and left side of the piece,' the researchers explained. 'These marks do not affect the upper surface, which displays the characteristic articulated segments of a trilobite's dorsal exoskeleton. It seems clear that the person who modified the stone intended to leave that natural surface untouched, while simultaneously adapting the fossil to its new function.' According to the study, the modified fossil could have functioned as a game token, a part of a necklace or bracelet, a banded pendant on a metallic mount, or simply an object people carried in their bag or pocket. Regardless of how the trilobite was fashioned, it was likely kept for supernatural, propitiatory, or medicinal purposes and abandoned between the first and third centuries CE. 'It is plausible to consider that the Armea trilobite may have been perceived to hold magical and protective powers for its wearer, as is the case with fossils or even trilobites in other well-known archaeological contexts,' the researchers wrote. Coincidentally, archaeologists found the trilobite next to a bronze coin of Augustus. The discovery is a testament to the fact that humanity's curiosity for that which came before us is a universal trait that transcends cultures, borders, and even time itself. It stands as a reassuring reminder, especially in times like these—when the only thing everyone seems to agree on is our many differences.
